Herantis Pharma Says New Clinical Evidence Validates HER-096 Phase 2 Design
Herantis Pharma says newly published clinical evidence validates the design of its HER-096 Phase 2 study.
Herantis Pharma says newly published clinical evidence validates the design of its HER-096 Phase 2 study.